Aura Biosciences Inc.

NASDAQ: AURA
Share price (3/21/25): $7.50
Market cap (3/21/25): $375 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 12/31/23 FY 2023 – amended

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Ownership Filter

Hopkins Janet Jill

De Los Pinos Elisabet

News Filter

Reports Third Quarter 2024 Financial Results and Business Highlights

Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-Sar in Patients With Non-Muscle-Invasive Bladder Cancer (NMIBC) in Ongoing Phase 1 Trial

Change in Directors, Officers or Compensation

Reports Positive Phase 2 End of Study Results Evaluating Bel-Sar as a First- Line Treatment for Early-Stage Choroidal Melanoma

Reports Second Quarter 2024 Financial Results and Business Highlights

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission